GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

L&C Bio Co 290650.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

22,550

-5.05%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩85.48bn

FY2016FY2025

Net income

−₩138.17bn

FY2016FY2025

Free cash flow

−₩4.47bn

FY2016FY2025

Shareholders' equity

₩198.22bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩85.48bn₩72.09bn₩65.93bn₩52.57bn₩45.68bn₩32.97bn₩29.15bn₩21.24bn₩17.90bn₩11.82bn
Gross profit₩45.39bn₩42.48bn₩33.86bn₩31.50bn₩28.45bn₩19.56bn₩18.66bn₩13.38bn₩11.14bn₩6.99bn
Research and development₩4.10bn₩4.91bn₩3.15bn₩2.20bn₩2.29bn₩2.38bn₩1.49bn———
Operating income₩4.42bn₩2.52bn—₩9.52bn₩13.17bn₩7.32bn₩9.03bn₩5.48bn₩4.87bn₩2.03bn
Net income−₩138.17bn₩141.06bn₩48.36bn₩4.54bn₩13.81bn₩10.81bn₩7.25bn₩5.21bn₩3.75bn₩1.98bn
Diluted earnings per share-5,682.326,218.422,131.86200.32608.97493.83328.38239.95209.51125.28

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩456.64bn₩475.60bn₩262.23bn₩199.73bn₩107.40bn₩80.58bn₩66.23bn₩57.38bn₩20.49bn₩15.66bn
Cash and short-term investments—₩24.14bn₩59.19bn₩12.32bn₩19.62bn₩27.34bn₩28.91bn₩36.58bn₩6.58bn₩3.88bn
Total liabilities₩248.10bn₩191.25bn₩115.29bn₩101.77bn₩22.38bn₩22.77bn₩8.04bn₩4.92bn₩3.68bn₩5.64bn
Debt₩4.02bn₩123.90bn₩82.13bn₩81.94bn₩6.83bn₩15.03bn₩1.79bn₩1.00bn₩463.0m₩3.53bn
Shareholders' equity₩198.22bn₩284.35bn₩146.94bn₩97.95bn₩85.02bn₩57.81bn₩58.18bn₩52.46bn₩16.81bn₩10.02bn
Shares outstanding24m23m23m23m23m22m22m22m18m16m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩12.56bn−₩8.57bn−₩12.13bn−₩6.08bn₩10.91bn₩7.42bn₩6.43bn₩3.85bn₩3.82bn−₩185.4m
Capital spending−₩17.04bn−₩5.35bn−₩24.98bn−₩37.53bn−₩10.25bn−₩3.02bn−₩1.96bn−₩4.74bn−₩285.3m−₩715.8m
Free cash flow−₩4.47bn−₩13.92bn−₩37.12bn−₩43.61bn₩655.7m₩4.40bn₩4.47bn−₩893.4m₩3.53bn−₩901.2m
Dividends paid−₩1.12bn−₩2.27bn−₩1.11bn−₩1.11bn−₩1.08bn−₩729.3m−₩729.3m−₩729.3m−₩729.3m—

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩38.79bn₩30.29bn₩24.67bn₩22.56bn₩20.58bn₩17.76bn₩19.09bn₩18.55bn
Gross profit₩23.61bn₩18.35bn₩13.09bn₩13.18bn₩9.37bn₩9.83bn₩9.15bn₩11.41bn
Operating income₩8.58bn₩6.00bn₩1.95bn₩2.90bn−₩245.1m−₩455.5m−₩622.3m₩174.8m
Net income−₩28.00bn₩2.60bn−₩72.56bn−₩51.46bn−₩13.73bn−₩427.6m₩143.62bn−₩5.17bn
Diluted earnings per share-1,137.48105.74-2,983.78-2,116.24-557.78-18.856,331.04-227.97
Cash from operations₩8.09bn₩8.16bn₩6.07bn₩3.79bn₩1.38bn₩1.33bn−₩8.57bn−₩8.93bn
Capital spending−₩15.25bn−₩7.71bn−₩8.68bn−₩3.10bn−₩4.35bn−₩909.0m−₩5.35bn−₩5.95bn
Free cash flow−₩7.16bn₩450.0m−₩2.61bn₩693.0m−₩2.97bn₩417.0m−₩13.91bn−₩14.88bn
Total assets₩477.43bn₩467.09bn₩456.64bn₩497.94bn₩489.67bn₩432.05bn₩475.60bn₩251.80bn
Cash and short-term investments—————₩14.10bn₩24.14bn₩26.69bn
Debt₩6.36bn₩4.01bn₩4.02bn₩18.66bn₩22.50bn₩52.56bn₩55.64bn₩11.31bn
Shareholders' equity₩324.77bn₩202.84bn₩198.22bn₩256.19bn₩313.16bn₩283.30bn₩284.35bn₩143.49bn

Financial ratios

Data as of 27 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin53.1%58.9%51.4%59.9%62.3%59.3%—
Operating margin5.2%3.5%—18.1%28.8%22.2%31.0%
Net margin-161.7%195.7%73.4%8.6%30.2%32.8%—
Return on equity-69.7%49.6%32.9%4.6%16.2%18.7%—
Return on assets-30.3%29.7%18.4%2.3%12.9%13.4%—
Revenue growth18.6%9.4%25.4%15.1%38.5%13.1%—
Earnings growth-198.0%191.7%964.2%-67.1%27.8%49.1%—
Current ratio0.59x0.84x1.28x3.43x8.45x12.38x—
Debt to equity0.02x0.18x0.06x0.82x0.06x0.24x—
Equity ratio43.4%59.8%56.0%49.0%79.2%71.7%—
Interest coverage0.75x0.78x—3.10x28.61x9.85x—
R&D as a share of sales4.8%6.8%4.8%4.2%5.0%7.2%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue17.6%21.0%25.2%
Operating income-22.6%-9.6%14.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin55.8%55.5%56.7%57.6%
Operating margin4.4%———
Net margin1.8%20.2%22.7%22.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-5.41.96.857.730.134.913.013.7
Price to sales8.73.85.05.09.111.53.23.4

Dividends and splits

Per share, in the currency the company pays

Paid for 7 years. Last went ex-dividend on 29 Dec 2025.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year24.17624.17648.35224.17624.17624.17616.117
  • 3-for-1 split · 12 Oct 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.